US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Vectors Coal ETF

94.92

0.0000

Volume:- -

Turnover:- -

Market Cap:35.12M

PE:- -

High:94.92

Open:94.92

Low:94.92

Close:94.92

52wk High:111.00

52wk Low:54.10

Shares:370.00K

Float Shares:370.00K

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

BioXcel Therapeutics Completes Market Opportunity Assessment and Advances Commercialization Plans for IGALMI® in the At-Home Setting

Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization

At ASH 2025 Oral Presentation, Immix Biopharma Reports Positive Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially First- and Best-in-Class Therapy for relapsed/refractory AL Amyloidosis

TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Future Market Opportunities

Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025

PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025

DAT Flywheel Stalling, Crypto KOL Suggests DAT Company Will Dump Reserves, Market Still Faces Deep Rekt

Press Release: Lantern Pharma Reports Third Quarter 2025 Financial Results and Provides Business Updates

SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies

Atea Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

ZachXBT: Prominent Crypto KOL Brandon Hong Fakes Investment Profit Screenshots

Unveiling the KOL Round: When Influence Turns into Capital, How is the Crypto Primary Market Reshaped?

What is the Curator role in DeFi? Could it be the dark horse of this cycle?

「Whale Hunting Operation」 Lead KOL Once Again Transfers $2.5 Million to Hyperliquid, Longing XPL with 1x Leverage

Crypto KOL: ChainOpera recently completed a $40 million funding round, bringing its total funding to over $50 million.

Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy

CBB Article Warns of High Leverage Risk in Stream's xUSD, Team Responds with Overcollateralization and Commitment to Increased Transparency

Esperion to Host Virtual Investor Key Opinion Leader Event Highlighting Significant Unmet Need in Statin Intolerance on Tuesday, November 11, 2025, at 2:00 p.m. ET.

Behind Coinbase's Acquisition of Echo: Cobie's 13-Year Journey from a $200 Entry into the Industry to Fame and Fortune

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KOL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KOL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KOL\",,,,,undefined,":{"symbol":"KOL","market":"US","secType":"STK","nameCN":"VanEck Vectors Coal ETF","latestPrice":94.92,"timestamp":1607979600000,"preClose":94.92,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":370000,"shares":370000,"eps":0,"marketStatus":"Delisted","change":0,"latestTime":"02-12 09:20:30 EST","open":94.92,"high":94.92,"low":94.92,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770906600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":94.92,"sharesOutstanding":370000,"nav":95.75227,"aum":35428340.72,"bidAskSpread":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KOL\",,,,,undefined,":{"symbol":"KOL","floatShares":370000,"roa":"--","roe":"--","lyrEps":0,"shares":370000,"dividePrice":0,"high":94.92,"amplitude":0,"preClose":94.92,"low":94.92,"week52Low":54.099,"pbRate":"--","week52High":111,"institutionHeld":0,"latestPrice":94.92,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":94.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KOL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-12-15","symbol":"KOL","reason":null,"defaultRemindTime":1608042600000,"announcedDate":"2020-12-04","type":"delisting","dateTimestamp":1608008400000},{"market":"US","date":"2020-12-11","symbol":"KOL","amount":3.2432,"defaultRemindTime":1607697000000,"name":"Market Vectors-Coal ETF","payableDate":"2020-12-14","currency":"USD","type":"dividend","dateTimestamp":1607662800000},{"market":"US","date":"2020-04-15","symbol":"KOL","type":"split","dateTimestamp":1586923200000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2019-12-23","symbol":"KOL","amount":0.939,"name":"Market Vectors-Coal ETF","payableDate":"2019-12-24","currency":"USD","type":"dividend","dateTimestamp":1577077200000},{"market":"US","date":"2018-12-20","symbol":"KOL","amount":0.824,"name":"Market Vectors-Coal ETF","currency":"USD","type":"dividend","dateTimestamp":1545282000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KOL\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-20","recordDate":null,"paymentDate":null,"value":0.824,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":null,"value":0.939,"currency":"USD"},{"executeDate":"2020-12-11","recordDate":"2020-12-14","paymentDate":null,"value":3.2432,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KOL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KOL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610923233","title":"BioXcel Therapeutics Completes Market Opportunity Assessment and Advances Commercialization Plans for IGALMI® in the At-Home Setting","url":"https://stock-news.laohu8.com/highlight/detail?id=2610923233","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610923233?lang=en_us&edition=fundamental","pubTime":"2026-02-12 20:00","pubTimestamp":1770897600,"startTime":"0","endTime":"0","summary":"Third party commercial assessment shows larger than expected potential total addressable market for IGALMI in the at-home setting Strong prescriber interest, patient demand, and positive payer feedbac","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/12/3237066/0/en/BioXcel-Therapeutics-Completes-Market-Opportunity-Assessment-and-Advances-Commercialization-Plans-for-IGALMI-in-the-At-Home-Setting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","HBCP","BK4195","BK4007","BK4539","BK4211","KOL","ESG"],"gpt_icon":0},{"id":"2590516989","title":"Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization","url":"https://stock-news.laohu8.com/highlight/detail?id=2590516989","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590516989?lang=en_us&edition=fundamental","pubTime":"2025-12-11 21:00","pubTimestamp":1765458000,"startTime":"0","endTime":"0","summary":"Inhibiting prolactin receptor (PRLR) signaling with the ABS-201 anti-PRLR antibody promotes human hair follicle growthex vivo Human ex vivo data validate ABS-201’s potential to reverse follicular mini","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/11/3203834/0/en/Absci-Reports-New-Human-Ex-Vivo-Data-Demonstrating-That-ABS-201-Stimulates-Hair-Growth-and-Regenerates-Stem-Cell-Niche-to-Potentially-Reverse-Follicle-Miniaturization.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","ABSI","KOL","BK4121"],"gpt_icon":0},{"id":"2589801826","title":"At ASH 2025 Oral Presentation, Immix Biopharma Reports Positive Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially First- and Best-in-Class Therapy for relapsed/refractory AL Amyloidosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2589801826","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589801826?lang=en_us&edition=fundamental","pubTime":"2025-12-08 07:15","pubTimestamp":1765149300,"startTime":"0","endTime":"0","summary":"– NXC-201 demonstrated a complete response (CR) rate of 75% (15/20) (at s/u IFE(-) level) by independent review committee – – In four out of five pending patients, MRD negativity in bone marrow predic","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/07/3201155/0/en/At-ASH-2025-Oral-Presentation-Immix-Biopharma-Reports-Positive-Phase-2-NXC-201-Results-Advancing-Toward-BLA-Submission-as-a-Potentially-First-and-Best-in-Class-Therapy-for-relapsed.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXC","IE0009354923.USD","BK4230","BK4022","BK4161","ODD","AL","KOL","CR","BK4104","LU2463526074.USD","LU1169590202.USD","BK4109","IE00B19Z6F94.USD","IE0034390439.USD","CAR","LU1169589451.USD","BK4572","ASH","BK4183"],"gpt_icon":0},{"id":"2589782202","title":"TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition","url":"https://stock-news.laohu8.com/highlight/detail?id=2589782202","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589782202?lang=en_us&edition=fundamental","pubTime":"2025-12-07 06:30","pubTimestamp":1765060200,"startTime":"0","endTime":"0","summary":"Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23) and overall survival (HR=0.61; p=0.52) 3/3 (100%) of TSC-101-treated patients who reached two-year follow-up re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/06/3201100/0/en/TScan-Therapeutics-Announces-Positive-Updated-Data-from-the-ALLOHA-Phase-1-Heme-Trial-at-the-67th-American-Society-of-Hematology-Annual-Meeting-and-Exposition.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4107","BK4539","BK4097","BK4109","BK4007","ASH","BK4117","BK4139","KOL","OS","AFG","LENZ","LU2463526074.USD"],"gpt_icon":0},{"id":"2588021738","title":"TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Future Market Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2588021738","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588021738?lang=en_us&edition=fundamental","pubTime":"2025-12-04 05:05","pubTimestamp":1764795900,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., Dec.  03, 2025  (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cel","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/03/3199335/0/en/TScan-Therapeutics-to-Host-Virtual-KOL-Event-to-Discuss-Clinical-Updates-from-the-ALLOHA-Phase-1-Trial-and-Future-Market-Opportunities.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2463526074.USD","BK4139","BK4588","HST","BK4218","BK4539","BK4181","LENZ","BK4109","KOL","ASH","BK4007","BK4585"],"gpt_icon":0},{"id":"2588708028","title":"Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2588708028","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588708028?lang=en_us&edition=fundamental","pubTime":"2025-12-02 05:05","pubTimestamp":1764623100,"startTime":"0","endTime":"0","summary":"KOL panel to discuss how vispa-cel, an anti-CD19 allogeneic CAR-T cell therapy, can broaden access for patients with second-line large B cell lymphoma including through use in the community setting BE","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/01/3197429/0/en/Caribou-Biosciences-to-Host-In-Person-and-Virtual-KOL-Event-at-ASH-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2463526074.USD","BK4181","BK4588","HST","CAR","KOL","BK4022","BK4539","BK4109","BK4218","ASH","BK4585","BK4139","CRBU","LD","BK4230"],"gpt_icon":0},{"id":"2586458476","title":"PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2586458476","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586458476?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:30","pubTimestamp":1764077400,"startTime":"0","endTime":"0","summary":"Internationally recognized colorectal surgeon Steven D. Wexner, MD, FACS, FRCS, to discuss the clinical and economic burden of surgical site infections and the therapeutic potential of D-PLEXPETACH TI","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/25/3194326/0/en/PolyPid-to-Participate-in-ROTH-Capital-Partners-Virtual-KOL-Event-on-December-10-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","KOL","BK4588","ROTH","BK4585","BK4520","BK4516","BK4007","X","PYPD"],"gpt_icon":0},{"id":"2585167650","title":"DAT Flywheel Stalling, Crypto KOL Suggests DAT Company Will Dump Reserves, Market Still Faces Deep Rekt","url":"https://stock-news.laohu8.com/highlight/detail?id=2585167650","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585167650?lang=en_us&edition=fundamental","pubTime":"2025-11-21 09:44","pubTimestamp":1763689440,"startTime":"0","endTime":"0","summary":"BlockBeats News, November 21st, Alliance DAO co-founder QwQiao reiterated his view in a post, \"The next bear market  will be worse than what most people here expect. Right now, there is a large group of 'dumb money' who know nothing about crypto buying spot and ETFs. Such a situation has never had a good outcome.\" The market may need another 50% deep retracement to 'shake out' the positions held by these people before the market can reestablish a solid foundation and continue its super cycle.\"Placeholder partner Chris Burniske also expressed a similar view, stating, \"The era of DAT selling has only just begun. Just as it rose all the way, it will now fall all the way.\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_live","url":"https://www.theblockbeats.info//en/flash/321390","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/321390","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["KOL","DAT"],"gpt_icon":0},{"id":"2583931765","title":"Press Release: Lantern Pharma Reports Third Quarter 2025 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2583931765","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583931765?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:30","pubTimestamp":1763040600,"startTime":"0","endTime":"0","summary":"Transformational Quarter Marked by Clinical Validation, Regulatory Progress, and Strategic Momentum in Commercial AI Platform Launch. --  LP-184 Phase 1a clinical trial results demonstrate all primary. endpoints achieved with 48% clinical benefit rate in evaluable cancer. patients at or above therapeutic dose threshold; marked tumor reductions. observed in patients with DNA damage repair mutations including CHK2, ATM,--  FDA Type C meeting completed, providing regulatory guidance and pathway. clarity for Starlight Therapeutics' planned pediatric CNS cancer trial in. --  LP-300 preliminary Phase 2 data presented from the HARMONIC trial. at the 66th Annual Meeting of the Japan Lung Cancer Society with further. clinical and patient data planned for a webinar in December.--  LP-284 clinical data showcased at 25th Annual Lymphoma, Leukemia &. Myeloma  Congress, generating interest from the biopharma and. clinical communities and initiating discussions for combination therapy. --  KOL-hosted","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4528","BK4139","KOL","BK4022","BK4555","BK4099","TM","AI","STRK","BK4596","BK4585","R","BK4516","BK4600","BK4023","BK4588","LTRN","BK4232","BK4604","03160","BK4551","BK4587","BK4543","BK4595"],"gpt_icon":1},{"id":"2583596976","title":"SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies","url":"https://stock-news.laohu8.com/highlight/detail?id=2583596976","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583596976?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:00","pubTimestamp":1763038800,"startTime":"0","endTime":"0","summary":"Company underscores its strengthened liquidity, cost reductions, and first revenue recorded from OsseoSculpt SALT LAKE CITY, Utah, Nov.  13, 2025  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/13/3187290/30038/en/SINTX-Reports-Pivotal-Third-Quarter-Business-Update-and-Financial-Highlights-Driven-by-FDA-Clearance-Product-and-IP-Portfolio-Expansions-and-Increased-Operational-Efficiencies.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1481599808.USD","SINT","BK4588","IP","LU1169589451.USD","LU2463526074.USD","BK4585","LU1487256676.USD","BK4136","IE00B3T34201.USD","LU1169590202.USD","LU1481600234.SGD","BK4082","KOL"],"gpt_icon":0},{"id":"2583586386","title":"Atea Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2583586386","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583586386?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:05","pubTimestamp":1762981500,"startTime":"0","endTime":"0","summary":"Patient Enrollment on Track in Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV), Topline Results from North America Trial Expected Mid-2026 New Data Show Bemnifosbuvir Has Unique Dual M","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/12/3186782/0/en/Atea-Pharmaceuticals-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOL","BK4007","HSCT","AVIR"],"gpt_icon":0},{"id":"2581854849","title":"ZachXBT: Prominent Crypto KOL Brandon Hong Fakes Investment Profit Screenshots","url":"https://stock-news.laohu8.com/highlight/detail?id=2581854849","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581854849?lang=en_us&edition=fundamental","pubTime":"2025-11-08 14:51","pubTimestamp":1762584660,"startTime":"0","endTime":"0","summary":"BlockBeats News, November 8th, Cryptocurrency sleuth ZachXBT posted a message stating that well-known crypto KOL Brandon Hong  was previously found to have forged investment profit screenshots last year. ZachXBT expressed confusion over why so many people still believe in him and are willing to pay to join his community.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_live","url":"https://www.theblockbeats.info//en/flash/319679","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/319679","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["KOL"],"gpt_icon":0},{"id":"2581000162","title":"Unveiling the KOL Round: When Influence Turns into Capital, How is the Crypto Primary Market Reshaped?","url":"https://stock-news.laohu8.com/highlight/detail?id=2581000162","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581000162?lang=en_us&edition=fundamental","pubTime":"2025-11-07 20:06","pubTimestamp":1762517160,"startTime":"0","endTime":"0","summary":"02 The Truth About the KOL Round: Some Strike It Rich, Some Fall to Zero2.1 The Profit and Loss Ends of the KOL RoundThe profit and loss performance of the KOL Round varies widely depending on the project and market conditions.In a bull marke","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_highlight","url":"https://www.theblockbeats.info/en/news/60137","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info/en/news/60137","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_highlight","symbols":["BK4206","KOL","TGE"],"gpt_icon":0},{"id":"2581728006","title":"What is the Curator role in DeFi? Could it be the dark horse of this cycle?","url":"https://stock-news.laohu8.com/highlight/detail?id=2581728006","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581728006?lang=en_us&edition=fundamental","pubTime":"2025-11-05 18:40","pubTimestamp":1762339200,"startTime":"0","endTime":"0","summary":"Original Article Title: \"What Is the Curator Role in DeFi?Could It Be a Landmine in This Cycle?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_highlight","url":"https://www.theblockbeats.info/en/news/60106","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info/en/news/60106","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_highlight","symbols":["KOL"],"gpt_icon":0},{"id":"2580270948","title":"「Whale Hunting Operation」 Lead KOL Once Again Transfers $2.5 Million to Hyperliquid, Longing XPL with 1x Leverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2580270948","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580270948?lang=en_us&edition=fundamental","pubTime":"2025-11-04 12:21","pubTimestamp":1762230060,"startTime":"0","endTime":"0","summary":"BlockBeats News, November 4th, according to HyperInsight monitoring, starting from 00:00 today, the leader KOL  of the \"Whale Hunting Squad,\" who had previously targeted the Insider Whale, ambushed XPL with a 1x leverage spot position at an average price of $0.277. The current position size has gradually increased to $800,000, with $3 million of funds remaining untouched, and continues to place limit orders for XPL below $0.27. Previously, this address had deposited $2.5 million into Hyperliquid over the past 6 days.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_live","url":"https://www.theblockbeats.info//en/flash/318991","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/318991","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["XPL","KOL","BK4168"],"gpt_icon":0},{"id":"2580944402","title":"Crypto KOL: ChainOpera recently completed a $40 million funding round, bringing its total funding to over $50 million.","url":"https://stock-news.laohu8.com/highlight/detail?id=2580944402","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580944402?lang=en_us&edition=fundamental","pubTime":"2025-11-01 12:53","pubTimestamp":1761972780,"startTime":"0","endTime":"0","summary":"BlockBeats News, November 1st, according to Crypto Fearless, the AI Layer1 project ChainOpera has recently completed a financing round of over $40 million, but has not disclosed the form of this financing, valuation, and participating institutions. The ChainOpera token COAl was listed on Binance Alpha and the contract on September 25th, with the price dropping to a minimum of $0.13. The token has been rising continuously since October 6th, reaching a peak of $20, and the current price has fallen back to around $1.5.Reportedly, in December 2024, ChainOpera announced the completion of a $17 million seed round of financing, led by Finality Capital, Road Capital, and IDG Capital. With this financing round of over $40 million, ChainOpera has raised a total of over $50 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_live","url":"https://www.theblockbeats.info//en/flash/318652","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/318652","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["KOL"],"gpt_icon":0},{"id":"2579172565","title":"Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2579172565","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579172565?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:01","pubTimestamp":1761854460,"startTime":"0","endTime":"0","summary":"-- Webcast event to begin at 8:00am ET on Wednesday, November 12, 2025 --CAMBRIDGE, Mass., Oct.  30, 2025  (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/30/3177878/0/en/Prime-Medicine-to-Host-Virtual-KOL-Event-to-Showcase-Wilson-s-Disease-Strategy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4181","HST","CTA","BK4218","BK4588","KOL"],"gpt_icon":0},{"id":"2579592809","title":"CBB Article Warns of High Leverage Risk in Stream's xUSD, Team Responds with Overcollateralization and Commitment to Increased Transparency","url":"https://stock-news.laohu8.com/highlight/detail?id=2579592809","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579592809?lang=en_us&edition=fundamental","pubTime":"2025-10-29 14:15","pubTimestamp":1761718500,"startTime":"0","endTime":"0","summary":"BlockBeats News, October 29th, Cryptocurrency Key Opinion Leader  CBB0FE issued a post warning that \"Stream's xUSD has only about $170 million in on-chain asset backing, yet it has borrowed about $530 million from various lending protocols. This means its leverage is as high as 4.1 times—built on a large number of extremely illiquid positions.This is not 'yield farming,' but outright degenerate gambling leverage speculation. Stay away from it. Do not touch anything related to the Morpho/Euler vaults.\"In response, Stream's founder stated, \"This week we are integrating third-party attestors. Currently, xUSD is fully collateralized and overcollateralized, with an insurance fund in place. Most of the funds are distributed across CEXs and DEXs not yet tracked by Debank. This lack of transparency will soon be addressed.xUSD was never designed to be a stablecoin. If the Crypto Twitter  community mistakenly thought it was a stablecoin, that is our responsibility for miscommunication. xUSD is a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_live","url":"https://www.theblockbeats.info//en/flash/318177","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/318177","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["BK4508","BK4077","KOL","BK4120","BK4516","BK4534","TISI","BK4579","TWTR"],"gpt_icon":0},{"id":"2578597929","title":"Esperion to Host Virtual Investor Key Opinion Leader Event Highlighting Significant Unmet Need in Statin Intolerance on Tuesday, November 11, 2025, at 2:00 p.m. ET.","url":"https://stock-news.laohu8.com/highlight/detail?id=2578597929","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578597929?lang=en_us&edition=fundamental","pubTime":"2025-10-28 20:00","pubTimestamp":1761652800,"startTime":"0","endTime":"0","summary":"– Leading Cardiovascular Physician Experts to Explore Real-World Challenges and Impact on Patient Outcomes – ANN ARBOR, Mich., Oct.  28, 2025  (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/28/3175334/0/en/Esperion-to-Host-Virtual-Investor-Key-Opinion-Leader-Event-Highlighting-Significant-Unmet-Need-in-Statin-Intolerance-on-Tuesday-November-11-2025-at-2-00-p-m-ET.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOL","BK4144","BK4007","BK4181","BK4218","BK4590","BK4561","ESPR","BK4585","BK4588","BK4581","HST","ET"],"gpt_icon":0},{"id":"2578930126","title":"Behind Coinbase's Acquisition of Echo: Cobie's 13-Year Journey from a $200 Entry into the Industry to Fame and Fortune","url":"https://stock-news.laohu8.com/highlight/detail?id=2578930126","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578930126?lang=en_us&edition=fundamental","pubTime":"2025-10-27 11:24","pubTimestamp":1761535440,"startTime":"0","endTime":"0","summary":"Original Article Title: \"The Story Behind Coinbase's Acquisition of Echo: Cobie's 13-Year Journey from a $200 Entry to Fame and Fortune\"Original Article Author: David, DeepTech TechFlowOn October 21, 2025, Coinbase announced the acquisition of the on-chain investment platform Echo for $375 million.Just the day before, Coinbase had spent $25 million to acquire an NFT, solely to revive a podcast. Two days, two transactions, totaling $400 million, all pointing to the same person:Jordan \"Cobie\" Fish.Who is Cobie?","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_highlight","url":"https://www.theblockbeats.info/en/news/60004","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info/en/news/60004","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_highlight","symbols":["BK4508","LU1861220207.SGD","ETH.USD.HKCC","BK4535","LU1861217088.USD","BK4516","APT.USD.HKCC","BK4594","TWTR","TON.USD.HKCC","BK4551","BK4554","BK4077","BK4600","TON.USD.CC","KOL","LU1861559042.SGD","BTC.USD.HKCC","BK4579","BK4539","APT.USD.CC","LU2360107671.USD","COIN","BK4112","BK4585","BK4534","BK4588","LU1861558580.USD","BK4596","MBTmain","BK4595","BTC.USD.CC","LDO.USD.HKCC","BK4601"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":54,"code":"91000000","status":"200"}]}}